Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Hematol Oncol ; 19(6): 399-405, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12186362

ABSTRACT

The authors sought to determine whether recombinant human thrombopoietin (TPO) acts synergistically with other cytokine(s) on burst-forming unit-erythroid (BFU-E)-derived and colony-forming unit-granulocyte/macrophage (CFU-GM)-derived colony formations from cord blood of premature neonates. Cord blood nonadherent mononuclear cells (MNC) from normal premature neonates were cultured in a methylcellulose system. When cultured with 1 x 10(4) MNC/mL, erythropoietin (EPO) 2 U/mL, interleukin-3 (IL-3) 50 ng/mL, and/or TPO 100 ng/mL, the addition of TPO to EPO gave rise to more BFU-E-derived colonies (p = .000). The addition of TPO to EPO + IL-3 gave rise to more BFU-E-derived colonies (p = .002) also. TPO synergizes erythropoiesis from cord blood of premature neonates. Likewise, the addition of TPO to G-CSF gave rise to more CFU-GM-derived colonies (p = .000) also. TPO synergizes myelopoiesis from cord blood of premature neonates. Thus, TPO has synergistic effects on both erythropoiesis and myelopoiesis from cord blood of premature neonates.


Subject(s)
Erythropoiesis/drug effects , Erythropoietin/pharmacology , Fetal Blood/cytology , Granulocyte Colony-Stimulating Factor/pharmacology , Interleukin-3/pharmacology , Myelopoiesis/drug effects , Thrombopoietin/pharmacology , Cells, Cultured , Drug Synergism , Humans , Infant, Newborn , Infant, Premature , Recombinant Proteins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...